Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Haifa A. Alhaidal"'
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali Altebainawi, Reham Alharbi, Maha Assadoon, Ramesh Vishwakarma, Nadia H. Ismail, Asma A. Alshehri, Faisal E. Al Mutairi, Mashael AlFaifi, Abdullah F. Alharthi, Abeer A. Alenazi, Mai Alalawi, Omar Al Zumai, Hussain Al Haji, Sarah T. Al Dughaish, Abdulrahman S. Alawaji, Haifa A. Alhaidal, Ghassan Al Ghamdi
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Previous studies have shown mortality benefits with corticosteroids in Coronavirus disease-19 (COVID-19). However, there is inconsistency regarding the use of methylprednisolone over dexamethasone in COVID-19, and this has not bee
Externí odkaz:
https://doaj.org/article/b943874714ce4ccb84fd5d336272a740
Autor:
Ohoud Aljuhani, Khalid Al Sulaiman, Ghazwa B Korayem, Aisha Alharbi, Ali F. Altebainawi, Shatha A. Aldkheel, Sarah G. Alotaibi, Ramesh Vishwakarma, Hanan Alshareef, Samiah Alsohimi, Mashael AlFaifi, Abdulrahman Al Shaya, Haifa A. Alhaidal, Raghad M. Alsubaie, Hessah Alrashidi, Khalid J. Albarqi, Dalal T. Alangari, Reem M. Alanazi, Noora M. Altaher, Hasan M. Al-Dorzi
Publikováno v:
Renal Failure, Vol 45, Iss 2 (2023)
Tocilizumab (TCZ) is recommended in patients with COVID-19 who require oxygen therapy or ventilatory support. Despite the wide use of TCZ, little is known about its safety and effectiveness in patients with COVID-19 and renal impairment. Therefore, t
Externí odkaz:
https://doaj.org/article/ca2f1083e62d4c88939688b4397622d0
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Reham Alharbi, Maha Assadoon, Ramesh Vishwakarma, Nadia H. Ismail, Asma A. Alshehri, Faisal E. Al Mutairi, Mashael AlFaifi, Abdullah F. Alharthi, Abeer A. Alenazi, Mai Alalawi, Omar Al Zumai, Hussain Al Haji, Sarah T. Al Dughaish, Abdulrahman S. Alawaji, Haifa A. Alhaidal, Ghassan Al Ghamdi
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/5c5adcf0537c44f58269ae2bc8021748
Autor:
Yousif S. Alakeel, Ebtihal F. Alharbi, Haifa A. Alhaidal, Aisha M. Jumaa, Latifah K. Albaiahy, Noura S. Alsagami, Shatha A. Alshahrani
Publikováno v:
Journal of Infection and Public Health, Vol 15, Iss 1, Pp 56-64 (2022)
Background: There is conflicting evidence regarding the effect of asthma and its different therapeutic options on COVID-19 severity and the clinical outcomes. Aim: This study aimed to investigate the relationship between using inhaled corticosteroids
Externí odkaz:
https://doaj.org/article/149288528cb04519be96bf4f87095b1f